Follicle stimulating hormone and estradiol alter immune response in osteoarthritic mice in an opposite manner.

Autor: Belenska-Todorova L; Department of Biology, Medical Genetics and Microbiology, Sofia University, Medical Faculty, Sofia, Bulgaria., Zhivkova R; Department of Biology, Medical Faculty, Medical University-Sofia, Sofia, Bulgaria., Markova M; Department of Biology, Medical Faculty, Medical University-Sofia, Sofia, Bulgaria., Ivanovska N; Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Jazyk: angličtina
Zdroj: International journal of immunopathology and pharmacology [Int J Immunopathol Pharmacol] 2021 Jan-Dec; Vol. 35, pp. 20587384211016198.
DOI: 10.1177/20587384211016198
Abstrakt: Although a number of studies have shown that the occurrence and progression of osteoarthritis (OA) is related to endocrine system dysfunction, there is limited evidence about what roles sex hormones play. The aim of the present study was to examine the capacity of 17β-estradiol (ED) and follicle stimulating hormone (FSH) to alter the differentiation of bone marrow (BM) cells in arthritic mice. The experiments were conducted in collagenase-induced osteoarthritis in mice. Cartilage degradation was observed by safranin and toluidine blue staining. Flow cytometry was used to define different BM and synovial cell populations. The influence of FSH and ED on osteoclastogenesis was studied in BM cultures and on the osteoblastogenesis in primary calvarial cultures. The levels of IL-8, TNF-α, FSH, and osteocalcin were estimated by ELISA. FSH increased cartilage degradation and serum osteocalcin levels, while ED abolished it and lowered serum osteocalcin. FSH elevated the percentage of monocytoid CD14+/RANK+ and B cell CD19+/RANK+ cells in contrast to ED which inhibited the accumulation of these osteogenic populations. Also, ED changed the percentage of CD105+/F4/80+ and CD11c+ cells in the synovium. FSH augmented and ED suppressed macrophage colony-stimulating factor (M-CSF) + receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast (OC) formation, and this correlated with a respective increase and decrease of IL-8 secretion. FSH did not influence osteoblast (OB) formation while ED enhanced this process in association with changes of TNF-α, IL-8, and osteocalcin production. ED reduced osteoclast generation in bone. The key outcome of the current study is that both hormones influenced BM cell differentiation, with FSH favoring osteoclast formation and ED favoring osteoblast accumulation.
Databáze: MEDLINE